E. Suyani Et Al. , "Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A*03, B*44) or Poorer (HLA B*51, C*04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers," 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , vol.120, Georgia, United States Of America, 2012
Suyani, E. Et Al. 2012. Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A*03, B*44) or Poorer (HLA B*51, C*04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers. 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Georgia, United States Of America).
Suyani, E., Bakanay, S. M., DALVA, K., Cakmak, E., Haznedar, R., Sncak, G., ... BEKSAÇ, M.(2012). Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A*03, B*44) or Poorer (HLA B*51, C*04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers . 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America
Suyani, Elif Et Al. "Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A*03, B*44) or Poorer (HLA B*51, C*04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers," 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 2012
Suyani, Elif Et Al. "Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A*03, B*44) or Poorer (HLA B*51, C*04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers." 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Georgia, United States Of America, 2012
Suyani, E. Et Al. (2012) . "Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A*03, B*44) or Poorer (HLA B*51, C*04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers." 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Georgia, United States Of America.
@conferencepaper{conferencepaper, author={Elif Suyani Et Al. }, title={Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A*03, B*44) or Poorer (HLA B*51, C*04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers}, congress name={54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Georgia}, country={United States Of America}, year={2012}}